July 6, 2017 (ecancer)
Dr Lin speaks with ecancer at EHA 2017 about clinical and biologic outcomes in patients with refractory aggressive Non-Hodgkin Lymphoma (NHL) treated with CAR T cell therapy.
VIDEO: ZUMA1 trial of CD19 CAR T cells for aggressive NHL
